Damon

Terrence M. Connors, Esquire, to Receive the 2023 American Inns of Court Professionalism Award for the Second Circuit

Retrieved on: 
Tuesday, September 26, 2023
Legal, Thought Leadership, Professional Services, Philanthropy, University, Other Philanthropy, Foundation, Other Professional Services, Education, LLP, St. John's University School of Law, Professional, Upstate New York, Canisius College, Lawrence J. Vilardo, Cornell Law School, United States Court of Appeals for the Second Circuit, Lawyer, Mentorship, Criminal defense lawyer, Connors, State government, Hon, Student, American College of Trial Lawyers, District court, Damon, City, American Inns of Court, School, American Bar Foundation, International Academy, American College, Douglas v. U.S. District Court ex rel Talk America, Practice of law, Law

Terrence M. Connors has been selected to receive the 2023 American Inns of Court Professionalism Award for the Second Circuit .

Key Points: 
  • Terrence M. Connors has been selected to receive the 2023 American Inns of Court Professionalism Award for the Second Circuit .
  • Chief Judge Debra Ann Livingston of the U.S. Court of Appeals for the Second Circuit will present the award to Connors at a later date.
  • Thurgood S. Marshall Award as the Outstanding Practitioner in the state from the New York State Association of Criminal Defense Lawyers.
  • The American Inns of Court, in Alexandria, Virginia, inspires the legal community to advance the rule of law by achieving the highest level of professionalism through example, education, and mentoring.

Ormco Launches Industry Leading Treatment Coordinator Program

Retrieved on: 
Tuesday, June 20, 2023
Orthodontics, Research and development, Mini, Envista Forensics, Education, Parent, 3D, Light, Clear, 2D, Damon, TCS, Patient, Knowledge, Treatment, TC, Dentistry, Nursing, Danaher Corporation

BREA, Calif., June 20, 2023 /PRNewswire/ -- With over 60 years providing innovative products, solutions, and education to the orthodontic community, Ormco today announces the unveiling of the first Treatment Coordinator (TC) Program and online Connective Portal from an orthodontic manufacturer, solely focused on the needs of the TC role. Immediately following its recent brand refresh and new tagline, "Driving the future of orthodontics, together", this launch demonstrates Ormco's continual investment in its orthodontic partners and its businesses.

Key Points: 
  • Ormco announces its Treatment Coordinator Program and online Connective Portal, focused on the needs of the TC role.
  • "We are thrilled to launch the very first Treatment Coordinator Program of its kind which recognizes what a unique and critical role they play in the practice converting patient consultations into active starts and influencing a positive treatment experience," said Eric Conley, President of Ormco.
  • Ormco's exclusive Treatment Coordinator Program and Connective Portal offers:
    The job of helping potential patients make the right decision for their treatment goals and lifestyle is not a simple task.
  • "The development of this program was inspired by Ormco Treatment Coordinators solely for TC's and is yet another way Ormco continuously and intentionally invests in people and my business," said Dr. Todd Bovenizer.

Damon Runyon launches new pediatric cancer fellowship in partnership with St. Jude Children’s Research Hospital

Retrieved on: 
Thursday, June 8, 2023
Nobel Prize, Partnership, Survival, NCI-designated Cancer Center, National Cancer Institute, Damon Runyon Cancer Research Foundation, Research, Bangladesh Technical Education Board, Science, Retirement, Damon, Cancer, Fellows, ARD International Music Competition, Sickle cell disease, Diagnosis, Hospital, Social media, Nursing, Pharmaceutical industry, Jude the Apostle

NEW YORK, N.Y. and MEMPHIS, Tenn., June 08, 2023 (GLOBE NEWSWIRE) -- The Damon Runyon Cancer Research Foundation and St. Jude Children’s Research Hospital announced a new pediatric-focused fellowship today.

Key Points: 
  • NEW YORK, N.Y. and MEMPHIS, Tenn., June 08, 2023 (GLOBE NEWSWIRE) -- The Damon Runyon Cancer Research Foundation and St. Jude Children’s Research Hospital announced a new pediatric-focused fellowship today.
  • Jude Pediatric Cancer Research Fellowship will fund up to 25 fellowships over eight years, a $9 million investment.
  • “Damon Runyon is uniquely positioned to identify gaps in the cancer research landscape, and the underfunding of pediatric cancer research has been a concern of ours for years,” said Yung S. Lie, Ph.D., President and CEO of the Damon Runyon Cancer Research Foundation.
  • To accelerate breakthroughs, the Damon Runyon Cancer Research Foundation provides today's best young scientists with funding to pursue innovative research.

Ajax Therapeutics Appoints Eric S. Fischer, PhD, to Scientific Advisory Board

Retrieved on: 
Wednesday, May 24, 2023
Biotechnology, Pharmaceutical, Health, Oncology, SAB, Biochemistry, Friedrich Miescher Institute for Biomedical Research, Dana–Farber Cancer Institute, JAK, University, Research, Biomedical Research, Computational chemistry, Doctor of Philosophy, Associate, Harvard Medical School, Pancreatic serous cystadenoma, Damon, Ajax, Translational research, Memorial Sloan Kettering Cancer Center, Proximity, JAK2, Pharmacology, Therapy, Chemical biology, MPN, Disease, Pharmaceutical industry, Leukemia, Thalidomide

Ajax Therapeutics, Inc. , a biopharmaceutical company applying computational chemistry and structure-based technologies to develop first-in-class and best-in-class JAK inhibitors for myeloproliferative neoplasms (MPNs), today announced the appointment of Eric S. Fischer, PhD, to the Company’s Scientific Advisory Board (SAB).

Key Points: 
  • Ajax Therapeutics, Inc. , a biopharmaceutical company applying computational chemistry and structure-based technologies to develop first-in-class and best-in-class JAK inhibitors for myeloproliferative neoplasms (MPNs), today announced the appointment of Eric S. Fischer, PhD, to the Company’s Scientific Advisory Board (SAB).
  • Dr. Fischer is a global leader in targeted protein degradation with appointments at Dana-Farber Cancer Institute (Dana-Farber) and Harvard Medical School.
  • He is a co-founder of Civetta Therapeutics, Neomorph, Inc. and Proximity Therapeutics.
  • Dr. Fischer completed his undergraduate training at the Universities of Hamburg and Basel and his doctoral training at the Friedrich Miescher Institute for Biomedical Research.

Hinge Bio Expands Senior Management Team to Drive GEM-DIMER™ Programs to Clinical Development

Retrieved on: 
Wednesday, January 18, 2023
Damon, American Cancer Society, Sofinnova, University of California, San Francisco, Economics, University, Series, Norwest Venture Partners, Fellow, Partnership, Daclizumab, IPO, FDA, Sutro Biopharma, Drug development, Cain (band), BD, Intellectual property, Growth, Therapy, GlaxoSmithKline, Drug discovery, Business development, Patient, Villanova School of Business, PDL BioPharma, Pfizer, PDL, Sale, Innovation, Acquisition, UCSF, Business, Management, Pharmaceutical industry, Fine chemical, Biophysics, Research, Biology

BURLINGAME, Calif., Jan. 18, 2023 (GLOBE NEWSWIRE) -- Hinge Bio, Inc., a privately-held biotechnology company, today announced the expansion of its senior management team, which is expected to drive the Company’s GEM-DIMER™ programs, with an initial focus in oncology, to clinical development. Harold E. “Barry” Selick, Ph.D., a successful and distinguished biopharmaceutical scientist, senior executive and venture investor, was named as Chief Executive Officer. Carin Rollins, a Company co-founder, becomes Chief Operating Officer. Joshua Carle, an experienced business development executive from both the buy-side and sell-side, joins the Company as Chief Business Officer.

Key Points: 
  • Joshua Carle, experienced business development and R&D investment executive, appointed Chief Business Officer
    BURLINGAME, Calif., Jan. 18, 2023 (GLOBE NEWSWIRE) -- Hinge Bio, Inc., a privately-held biotechnology company, today announced the expansion of its senior management team, which is expected to drive the Company’s GEM-DIMER™ programs, with an initial focus in oncology, to clinical development.
  • Harold E. “Barry” Selick, Ph.D., a successful and distinguished biopharmaceutical scientist, senior executive and venture investor, was named as Chief Executive Officer.
  • Joshua Carle, an experienced business development executive from both the buy-side and sell-side, joins the Company as Chief Business Officer.
  • “Now is the time to add executives who can accelerate the clinical and business development activities of our powerful GEM-DIMER platform.

Saama Hires Life Sciences Expert, Dr. Clinton White, as Chief Delivery Officer

Retrieved on: 
Tuesday, November 15, 2022
Technology, Public Policy, Government, Healthcare Reform, Biotechnology, Health, Electronic Design Automation, Pharmaceutical, Data Management, Artificial Intelligence, Cloud, Automation, Foster School, Clinical trial, Biotechnology, Chemistry, Drug development, Georgia Institute of Technology College of Computing, Multimedia, University of Washington Department of Bioengineering, Enterprise Data Planning, Collection, Foster School of Business, CDO, Doctor of Philosophy, Birmingham, A Call for Unity, NIH, Growth, MBA, University, COVID-19, Damon, LSAC, Business, NDAS, Patient, Management, Medical device, Fine chemical, Pharmaceutical industry, California Institute of Technology

Life sciences solutions company Saama has hired Clinton White, Ph.D., MBA, to serve as Chief Delivery Officer (CDO).

Key Points: 
  • Life sciences solutions company Saama has hired Clinton White, Ph.D., MBA, to serve as Chief Delivery Officer (CDO).
  • Dr. White will oversee Saamas project delivery teams, helping to scale product development and drive customer success.
  • View the full release here: https://www.businesswire.com/news/home/20221115006151/en/
    Clinton White, Ph.D., MBA, joins Saama as Chief Delivery Officer (CDO).
  • Prior to joining Saama, Dr. White was the global head of oncology project delivery for an industry-leading global contract research organization (CRO).

Damon Motors Selects EMQX--The World's Leading Solution for Cloud-Connected Vehicle Infrastructure

Retrieved on: 
Tuesday, June 28, 2022
Shift, MQTT, Motorcycle, Movement, Engineering, Hyperdrive, Hypersport, Light-emitting diode, Perception, Damon, Radar, General manager, Machine learning, Solution, Internet, Database, EMQ, United States Aviator Badge, Safety, IOT, Transport, Video game console

STOCKHOLM, June 28, 2022 /PRNewswire/ -- Damon Motors, makers of the high-performance, all-electric HyperDrive motorcycle powertrain and flagship HyperSport and HyperFighter models, has selected EMQX Enterprise for its forthcoming vehicle data infrastructure.

Key Points: 
  • STOCKHOLM, June 28, 2022 /PRNewswire/ -- Damon Motors, makers of the high-performance, all-electric HyperDrive motorcycle powertrain and flagship HyperSport and HyperFighter models, has selected EMQX Enterprise for its forthcoming vehicle data infrastructure.
  • "The EMQX solution is a critical piece of our infrastructure facilitating Motorcycle connectivity to the cloud, securely and at scale," said Rob Charter, Director of Engineering at Damon.
  • Damon's CoPilot vehicle safety system collects road and ride data using an array of cameras, radar, and non-visual sensors.
  • "What Damon Motors is doing with CoPilot is a huge leap forward for vehicle connectivity and rider safety," commented Dylan Kennedy, General Manager of EMQ Technologies.

Damon Motors Appoints Cybele Negris, ICD.D to Board of Directors

Retrieved on: 
Wednesday, June 8, 2022
Automotive, General Automotive, Automotive Manufacturing, Manufacturing, Alternative Vehicles, Fuels, Motorcycles, Marketing, HR, Motion, Transport, BCAA, CEO, 2007 College Football Hall of Fame inductees, BC, Royal Canadian Mint, Female, Organization, Multimedia, Damon, Woman, Hypersport, Industry, Engine, Instagram, Business Roundtable, BlueShore Financial, Safety, Agriculture and Agri-Food Canada, Management, Romano Negri, Business, Agriculture

Damon Motors today introduced Cybele Negris as the newest member of its board of directors.

Key Points: 
  • Damon Motors today introduced Cybele Negris as the newest member of its board of directors.
  • She joins the Damon board as the company ramps up production of its HyperSport motorcycles and continues its global expansion.
  • View the full release here: https://www.businesswire.com/news/home/20220608005427/en/
    Damon Appoints Cybele Negris to board of directors.
  • She joins the Damon board as the company ramps up production of its HyperSport motorcycles and continues its global expansion.

Damon Motors HyperSport Wins 2022 Edison Best New Product Award

Retrieved on: 
Monday, April 25, 2022
Automotive, Sports, Technology, Other Technology, Alternative Vehicles, Fuels, Motor Sports, Motorcycles, Consumer, CEO, Engine, Edison Awards, Marketing, Perception, Hypersport, Damon, Clean technology, Recreation, Goal, COO, Review, Innovation, GOOD, Safety, Multimedia, Gold, Torque, Management, Seaweed

Damon Motors today announced its flagship HyperSport motorcycle has received a 2022 Edison Best New Product Award.

Key Points: 
  • Damon Motors today announced its flagship HyperSport motorcycle has received a 2022 Edison Best New Product Award.
  • View the full release here: https://www.businesswire.com/news/home/20220425005965/en/
    Damon Motors HyperSport Earns Gold in 2022 Edison Awards in Consumer SolutionsSports and Recreation Category (Graphic: Business Wire)
    At Damon, we continue to innovate and push the boundaries of what is possible on two wheels, said Jay Giraud, co-founder & CEO, Damon Motors.
  • The Damon HyperSport is proof that a motorcycle can have both style and substance, said Dom Kwong, co-founder & COO, Damon Motors.
  • The 2022 Edison Best New Product Award is the latest recognition for the HyperSport motorcycle.

Damon Motors HyperDrive Named a CES 2022 Innovation Awards Honoree

Retrieved on: 
Monday, January 3, 2022
Performance & Special Interest, Other Energy, Motorcycles, Alternative Vehicles, Fuels, Energy, General Automotive, Technology, Automotive, Environment, Other Transport, Transport, Other Technology, Safety, CES, Transport, Engineering, Hyperdrive, Founder CEO, Human, Damon, Engine, Perception, Wind, CEO, Las Vegas Convention Center, Hypersport, Technology, Acceleration

Damon Motors today announced that it has been named a CES 2022 Innovation Awards Honoree .

Key Points: 
  • Damon Motors today announced that it has been named a CES 2022 Innovation Awards Honoree .
  • Damon was selected for a CES Innovation Award from a record high number of over 1800 submissions.
  • The HyperDrive is in an elite class of its own and boasts some incredible numbers, said Jay Giraud, founder & CEO, Damon Motors.
  • Damon will showcase its HyperDrive technology with its flagship HyperSport and new HyperFighter models at CES 2022, January 5-7, 2022, at the Las Vegas Convention Center in booth CP-16.